Lack of difference in response to Rebetron by race in prior interferon non-responders (NRs) with chronic hepatitis C

Response rates among AA pts have been noted to be less than those in Cauc in some studies. The Wash, DC metropolitan area HCV investigators study enrolled a total of 151 pts [25 African Americans (AA), 126 Caucasians (Cauc)] with well-compensated chronic HCV who had failed Interferon (IFN) monotherapy, were enrolled into an open label trial of Intron A (3 or 5 MU tiw) plus Ribavirin (1–1.